# Genomics * **Definition:** The study of genomes, which involves the analysis of the complete set of DNA within an organism, including all of its genes, to understand genetic variations and their implications for health. * **Taxonomy:** Specialties / Genomics ## News * Selected news on the topic of **Genomics**, for healthcare technology leaders * 15.9K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 4/29/2025 | [**NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology ...**](https://www.prnewswire.com/news-releases/neogenomics-and-ultima-genomics-collaborate-to-expand-clinical-test-offerings-in-oncology-using-the-ug-100-sequencing-platform-302440640.html) | [[PR Newswire]] | | 4/29/2025 | [**NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform**](https://finance.yahoo.com/news/neogenomics-ultima-genomics-collaborate-expand-120000834.html) | [[Yahoo Finance]] | | 3/27/2025 | [**ERS Genomics and Jumpcode Genomics sign CRISPR/Cas9 license agreement**](https://www.prnewswire.com/news-releases/ers-genomics-and-jumpcode-genomics-sign-crisprcas9-license-agreement-302413371.html) | [[PR Newswire]] | | 3/27/2025 | [**ERS Genomics and Jumpcode Genomics sign CRISPR/Cas9 license agreement**](https://finance.yahoo.com/news/ers-genomics-jumpcode-genomics-sign-154900264.html) | [[Yahoo Finance]] | | 3/10/2025 | [**REGENE Genomics Celebrates 3 Years of Innovation: The Future of AI ... - Yahoo Finance**](https://finance.yahoo.com/news/regene-genomics-celebrates-3-years-181500629.html) | [[Yahoo Finance]] | | 3/10/2025 | [**REGENE Genomics Celebrates 3 Years of Innovation: The Future of AI -Based Healthcare**](https://markets.businessinsider.com/news/stocks/regene-genomics-celebrates-3-years-of-innovation-the-future-of-ai-genomics-based-healthcare-1034460778) | [[Business Insider Markets]] | | 3/5/2025 | [**Dovetail Genomics Certifies CNAG as First Certified Service Provider in Europe**](https://www.prnewswire.com/news-releases/dovetail-genomics-certifies-cnag-as-first-certified-service-provider-in-europe-302391136.html) | [[PR Newswire]] | | 2/27/2025 | [**Spatial Transcriptomics & Genomics Market Global Forecast 2025-2030 - Yahoo Finance**](https://finance.yahoo.com/news/spatial-transcriptomics-genomics-market-global-092800971.html) | [[Yahoo Finance]] | | 2/23/2025 | [**10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis**](https://www.prnewswire.com/news-releases/10x-genomics-unveils-innovation-roadmap-at-agbt-general-meeting-advancing-leadership-in-large-scale-single-cell-and-spatial-analysis-302382827.html) | [[PR Newswire]] | | 2/6/2025 | [**Government of Canada launches Canadian Genomics Strategy to drive innovation and ...**](https://finance.yahoo.com/news/government-canada-launches-canadian-genomics-150000679.html) | [[Yahoo Finance]] | | 1/30/2025 | [**Genomics Market to Grow by USD 5.21 Billion (2024-2028), Boosted by Rising Investments in R&D, with AI Driving Market Transformation - Technavio**](https://www.prnewswire.com/news-releases/genomics-market-to-grow-by-usd-5-21-billion-2024-2028-boosted-by-rising-investments-in-rd-with-ai-driving-market-transformation---technavio-302364352.html) | [[PR Newswire]] | | 1/30/2025 | [**Genomics Market to Grow by USD 5.21 Billion (2024-2028), Boosted by Rising Investments ...**](https://www.prnewswire.com/news-releases/genomics-market-to-grow-by-usd-5-21-billion-2024-2028-boosted-by-rising-investments-in-rd-with-ai-impacting-market-trends---technavio-302364792.html) | [[PR Newswire]] | | 1/15/2025 | [**Neurogenomics Market Forecast and Trends Analysis to 2031: Healthcare Investments and ...**](https://finance.yahoo.com/news/neurogenomics-market-forecast-trends-analysis-120000459.html) | [[Yahoo Finance]] | | 1/13/2025 | [**Spatial Genomics & Transcriptomics Market to Hit USD 995.7 Million by 2029 with 12.4AGR**](https://www.prnewswire.com/news-releases/spatial-genomics--transcriptomics-market-to-hit-usd-995-7-million-by-2029-with-12-4-cagr--marketsandmarkets-302348988.html) | [[PR Newswire]] | | 1/9/2025 | [**In 2024, Complete Genomics expanded U.S. manufacturing and technology capabilities toward a diversified, reliable supply chain for its flexible and cost-effective NGS solutions**](https://www.prnewswire.com/news-releases/in-2024-complete-genomics-expanded-us-manufacturing-and-technology-capabilities-toward-a-diversified-reliable-supply-chain-for-its-flexible-and-cost-effective-ngs-solutions-302347290.html) | [[PR Newswire]] | | 12/23/2024 | [**Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share**](https://finance.yahoo.com/news/singular-genomics-enters-agreement-acquired-133000209.html) | [[Yahoo Finance]] | | 11/13/2024 | [**Genomics Market to Hit USD 66.85 Billion by 2029 with 9.4AGR - MarketsandMarkets™**](https://www.prnewswire.com/news-releases/genomics-market-to-hit-usd-66-85-billion-by-2029-with-9-4-cagr--marketsandmarkets-302303803.html) | [[PR Newswire]] | | 9/30/2024 | [**Genomics plc Announces David Thornton as President - PR Newswire**](https://www.prnewswire.com/news-releases/genomics-plc-announces-david-thornton-as-president-302261076.html) | [[PR Newswire]] | | 9/10/2024 | [**Is it possible to automate agrigenomics?**](https://www.news-medical.net/whitepaper/20240910/Is-it-possible-to-automate-agrigenomics.aspx) | [[News Medical Net]] | | 8/29/2024 | [**Precision Epigenomics Receives $2M Award from National Institutes of Health**](https://www.prweb.com/releases/precision-epigenomics-receives-2m-award-from-national-institutes-of-health-302233786.html) | [[PRWeb]] | | 7/29/2024 | [**Genomics Personalized Health Global Market 2024 To Reach $29.00 Billion By 2028 At ...**](https://tech.einnews.com/amp/pr_news/731200803/genomics-personalized-health-global-market-2024-to-reach-29-00-billion-by-2028-at-rate-of-16-1) | tech.einnews.com | | 7/26/2024 | [**Genomics Personalized Health Market to reach US$ 33 Billion by 2034, Driven by Advances ...**](https://www.prnewswire.com/news-releases/genomics-personalized-health-market-to-reach-us-33-billion-by-2034-driven-by-advances-in-next-generation-sequencing---transparency-market-research-inc-302207592.html) | [[PR Newswire]] | | 6/25/2024 | [**Dante Genomics Generative AI GenomeChat Aims at Becoming Doctors' and Patients' Best Partner for Advanced Genomics Solutions**](https://www.bignewsnetwork.com/news/274432804/dante-genomics-generative-ai-genomechat-aims-at-becoming-doctors-and-patients-best-partner-for-advanced-genomics-solutions) | bignewsnetwork.com | | 6/25/2024 | [**Dante Genomics Generative AI GenomeChat Aims at Becoming Doctors' and Patients' Best Partner for Advanced Genomics Solutions**](https://markets.businessinsider.com/news/stocks/dante-genomics-generative-ai-genomechat-aims-at-becoming-doctors-and-patients-best-partner-for-advanced-genomics-solutions-1033503396) | [[Business Insider Markets]] | | 6/24/2024 | [**Global Genomics Industry Research 2024: Rising Adoption of Personalized Medicines and Gene Therapies - Forecasts to 2031 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20240624828195/en/Global-Genomics-Industry-Research-2024-Rising-Adoption-of-Personalized-Medicines-and-Gene-Therapies---Forecasts-to-2031---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Complete Genomics**: A provider of high-quality sequencing services, enhancing access to genomic technologies through partnerships. - **Genomics England**: A public company that aims to improve healthcare through genomic research and initiatives, collaborating with various organizations to enhance early diagnosis and intervention. - **Nucleus Genomics**: Focuses on democratizing access to genetic testing and providing insights into genetic predispositions for various health conditions. - **NeoGenomics**: A company specializing in cancer diagnostics and genomic testing, recently introducing new assays for rapid genetic profiling. - **10x Genomics**: A life sciences company focused on innovative biological analysis tools, involved in multiple collaborations to advance genomics. - **NeoGenomics, Inc.**: A company focused on cancer genetics testing and precision oncology solutions. - **ACT Genomics**: Integrates genomics and proteomics to improve cancer care insights and personalized treatment strategies. - **10X Genomics**: A life science technology company focused on developing products that enhance the understanding of biological systems, particularly in single-cell and spatial biology. - **Genomics plc**: A company focused on drug discovery using human genetics and machine learning, collaborating with Vertex Pharmaceuticals. - **Ultima Genomics**: A company providing advanced sequencing technology, collaborating with Labcorp to improve genetic testing. - **ERS Genomics**: Holds a significant patent portfolio for CRISPR technology, enabling advancements in genomic research. - **Phase Genomics**: Utilizes ultra-long-range genome sequencing technology for genome assembly and microbiome discovery, recently appointed David Shoultz as Chief Business Officer. - **Dante Genomics**: A genomics and personalized medicine company integrating Generative AI features into its Whole Genome platform. - **REGENE Genomics**: An Indonesian biotechnology company focused on personalized healthcare through AI and DNA analysis. - **ERS Genomics Limited**: A company that holds a global portfolio of CRISPR/Cas9 patents, recently partnered with Université de Montréal to enhance genomic research capabilities. ### Partnerships and Collaborations - **10x Genomics and Garvan Institute**: Collaboration on the TenK10K project to map human cells and uncover genomic fingerprints associated with diseases. - **NeoGenomics and various pharmaceutical firms**: Collaboration to advance cancer care through precision medicine and enhance patient outcomes. - **ACT Genomics and mProbe**: Exclusive integration of OncoOmicsDX to bridge genomics and proteomics for improved cancer treatment insights. - **Genomics plc and Vertex Pharmaceuticals**: Extended collaboration to enhance drug discovery using human genetics and machine learning. - **Complete Genomics and Eurofins Clinical Enterprise**: Partnership to enhance access to high-quality sequencing services using advanced sequencing technologies. - **NeoGenomics and Duke University**: Collaborating to improve prognostic tools and therapeutic decision-making for blood cancer patients. - **Revvity and Genomics England**: Expanded collaboration to enhance genomic initiatives in the UK, focusing on the Generation Study for screening newborns for rare genetic conditions. - **Complete Genomics and NVIDIA**: Strategic partnership to improve genomic sequencing analysis and expand library preparation product offerings. - **Jumpcode Genomics and ERS Genomics**: License agreement to utilize CRISPR technology for enhancing next-generation sequencing. - **NeoGenomics and ConcertAI**: Launched CTO-H, a software-as-a-service solution for hematological diseases, enhancing clinical trial design and research analytics. - **Twist Bioscience and Curio Genomics**: Collaboration to streamline next-generation sequencing workflows in agricultural genomics. - **Dante Genomics and AWS**: Introduction of the GenAI Platform to enhance clinical understanding of genomic data. - **ACT Genomics and LSI Medience**: Partnership to explore genomic and clinical testing services tailored to the Japanese healthcare landscape. - **ERS Genomics and Université de Montréal**: A non-exclusive CRISPR/Cas9 license agreement to enhance genomic research capabilities. - **PacBio and 10x Genomics**: Collaboration to enhance sequencing solutions for researchers globally. - **Integrated DNA Technologies and Innovative Genomics Institute**: Partnership to create CRISPR treatments for genetic disorders. - **Labcorp and Ultima Genomics**: Expanded collaboration to utilize Ultima's sequencing technology for new clinical applications in oncology. - **Genoks and Velsera**: Collaboration to integrate Clinical Genomics Workspace into Genoks' cancer diagnostic services. - **Ubie and Nucleus Genomics**: Partnering to enhance access to genetic screening and early disease detection through AI-powered symptom checking and advanced genetic testing. ### Innovations, Trends, and Initiatives - **Next-Generation Sequencing (NGS)**: Revolutionizing genomics by enabling large-scale sequencing and reducing costs, making genomic analysis more accessible. - **Wellness Genomics**: Utilizing genetic information to enhance individual health through predictive testing and tailored wellness plans. - **Single Cell Genomics**: Emerging as a crucial aspect of scientific research, leading to discoveries in diseases and cures. - **Genotyping Market Growth**: Projected to grow from $17.9 billion in 2023 to $59.31 billion by 2032, driven by advancements in genomics and biotechnology. - **Genomic Market Growth**: The global genomics market is projected to grow significantly, driven by advancements in personalized treatments and gene therapy. - **Functional Genomics Platform by IRBM**: Designed to enhance genetic target identification and validation using advanced CRISPR methodologies. - **GenAI Platform**: Dante Genomics' new platform designed to provide personalized insights into genomic data. - **Envisioning a More Just Genomics**: A report focusing on enhancing justice in genomics, aiming for health equity and addressing ethical implications. - **Canadian Genomics Strategy**: A government initiative investing $175.1 million to enhance genomics research and its applications in personalized medicine and advanced diagnostics. - **Pharmacogenomics**: Integrates genetics and pharmacology to personalize drug therapy, optimizing treatment outcomes and minimizing adverse effects. - **Spatial Transcriptomics**: Emerging as a transformative tool for precision medicine, enabling detailed mapping of molecular interactions within tissues. - **3D Genomic Portfolio**: Dovetail's advanced genomic products, including Omni-C and Micro-C, enhancing genomic research capabilities. - **Clinical Genomics Workspace**: A platform by Velsera integrated into Genoks' services to improve cancer diagnostics. - **Generative AI in Genomics**: Dante Genomics integrates Generative AI into its Whole Genome platform to enhance data accessibility and interpretation. - **Davis Family Center for Preventive Genomics**: Aims to provide proactive genomic information to improve prevention and screening protocols. - **EvoMG Program**: A joint program in Barcelona combining evolutionary medicine and medical genomics to enhance understanding of disease mechanisms. - **UG 100 Sequencer**: Ultima Genomics' innovative sequencing technology that reduces costs and enhances whole genome sequencing services. - **Metagenomics Market Growth**: Projected to reach $6.71 billion by 2031, driven by advancements in sequencing technologies. ### Challenges and Concerns - **Data Security and Privacy**: Concerns regarding the protection of genetic data and potential misuse in genomics. - **Ethical Issues**: Concerns surrounding sequencing-based diagnosis and the implications of genomic data privacy. - **Ethical Considerations**: The need for trained professionals to interpret complex genomic data and address privacy concerns regarding genetic information. - **Data Privacy**: Concerns regarding the use of genetic data and ensuring patient confidentiality in genomic research and applications. - **Complex Data Interpretation**: Challenges in interpreting genomic data can hinder research and clinical applications. - **Global Disparities**: The COVID-19 pandemic highlighted disparities in the adoption of genomic technologies across different regions. - **Regulatory and Compliance Issues**: Companies in the genomics sector face challenges related to regulatory compliance and the need for standardized practices. - **Data Security**: Concerns over data security in genomics research and applications remain a significant challenge. - **High Sequencing Costs**: A significant barrier to widespread adoption of genomic technologies, particularly in metagenomics. - **Data Privacy Regulations**: Concerns regarding genomic data privacy and compliance with regulatory standards. - **Interoperability Issues**: Challenges in integrating various systems and technologies hinder the effective use of genomic data. - **Equitable Access**: There are concerns regarding the equitable distribution of genomic advancements and addressing diversity in genomics research. - **Ethical and Regulatory Challenges**: As AI-driven genomic analysis becomes prevalent, navigating ethical and regulatory challenges is crucial for healthcare systems. - **Standardization Issues**: Lack of standardized approaches in genomics hindering market growth and research consistency. - **Skilled Personnel Shortage**: The genomics sector faces a shortage of skilled professionals, impacting research and development efforts. - **Pharmacogenomics Implementation**: Challenges include limited physician-patient communication and the need for personalized approaches to fully realize its benefits. - **Shortage of Skilled Personnel**: A lack of trained professionals in genomics poses challenges for the industry's expansion. - **Lack of Standardization**: The absence of standardized approaches in genomics can hinder market growth and adoption. ## Related Topics [[Genomic Analysis]]; [[Laboratory Genomics]]; [[Clinical Genomics]]; [[Genomic Sequencing]]; [[Genome Editing]]; [[Genetic Testing]]; [[Medical Genetics]]